Skip to main content

Lindsay Dudfield, Executive Director and CEO of Jindalee Resources Limited, Executed MOU with POSCO Holdings For Joint Research At McDermitt Lithium Project

JINDALEE RESOURCES LIMITED  (ASX: JRL) (Jindalee, the Company) is an Australian exploration company with Tier 1 lithium deposits in its portfolio in the United States. The Company’s core goals are to discover world-class mineral deposits and generate shareholder wealth. The United States is one of the largest marketplaces for lithium demand, and Jindalee is a leading company committed to help meet future demand. The Company is focussing efforts into developing its McDermitt lithium deposit. Jindalee Resources was listed on the Australian Securities Exchange (ASX) on 11th July 2002 and raised AUD 2.70 million. Now, it is a pure-play United States lithium company. Jindalee’s Projects: In June 2018, the Company acquired McDermitt and Clayton North, two lithium sediment projects in the United States. Both projects are 100% owned by HiTech Minerals Inc., a wholly owned, US-based subsidiary of Jindalee. Several factors attracted the Company’s interest in these projects including: Potenti...
Post a Comment

Roquefort Therapeutics Reports In-Vivo Safety For Midkine Oncology Antibodies

ROQUEFORT THERAPEUTICS (LSE: ROQ, OTCQB: ROQAF) (“Roquefort” or the “Company”) ANNOUNCES that two of its Midkine (MDK) antibody programs, ROQ-A1 and ROQ-A2, demonstrate in-vivo safety in the pre-clinical development programs. The pre-clinical programs were carried out by leading cancer research groups.

ROQ-A1 and ROQ-A2 are two patented antibody medicines designed by Roquefort to target metastatic breast cancer and metastatic lung cancer. The experiments demonstrated that ROQ-A1 and ROQ-A2 bind specifically to MDK receptors in cancerous cells in the breast and lung and kill cancer in vitro.

Antibody programs targeting metastatic lung and breast cancer commenced in Q4 2022 at Olivia Newton-John Cancer Research Institute (La Trobe University), Hawkins Laboratory Biochemistry and Genetics (La Trobe University). Both antibodies have demonstrated good safety profiles validated in in-vivo models. The targets and milestones were achieved within budget and on time. 

 AJAN REGINALD, the CEO of Roquefort, said, “Roquefort focused on treatment fields with the highest unmet need. Even with the advancements in medicine in the last 30 years, some cancers are still poorly treated. Metastatic breast cancer & metastatic lung cancer have poor prognoses even with the best treatments. Overall mortality rates can be as high as 70%. That is why Midkine may be a good target, and these antibodies were engineered to target Midkine in these cancers.”

What’s Next?

ROQUEFORT will be COMMENCING EFFICACY PROGRAMS on ROQ-A1 and ROQ-A2. Efficacy programs will involve testing the efficiency of ROQ-A1 and ROQ-A2 to kill cancer by first shrinking tumours that start in the breast or lung of the patient or metastasised tumour, i.e., those tumours that usually start in either the lung or the breast and then spread to other organs.

If you’re interested in learning more about ROQUEFORT THERAPEUTICS, visit the OFFICIAL WEBSITE now.

Resource Link



Labels:
Location: Australia

Comments

Post a Comment

Popular posts from this blog

VRX Silica Limited Is All Set For The Arrowsmith North Silica Sand Project: Signed Power LOI With ResourcesWA

  VRX SILICA LIMITED   (ASX: VRX) (VRX or Company) has signed a   LETTER OF INTENT (LOI)   with ResourcesWA, a company   SPECIALISING IN ENERGY AND MINING CONSULTING . The LOI aims to explore a potential power supply solution for their Arrowsmith North Silica Sand Project by directly utilising gas from a nearby wellhead. The  OBJECTIVE  of the LOI is to assess the feasibility of setting up a powerhouse equipped with containerised gas reciprocating engines at a nearby gas wellhead location. The powerhouse would be connected to the existing gas plant through a direct offtake and reticulation to the Arrowsmith North site through a dedicated transmission line. ResourcesWA has a team with ample resources and expertise in project development, delivery, and asset management. The LOI provides a detailed proposal description and reflects the parties’ intentions for  SIX MONTHS . The proposal incorporates all design, construction, and operational requiremen...
Post a Comment
Read more

SLAM Exploration’s Mineral Claim Sale to Puma Exploration

  SLAM Exploration , a junior resource company listed under symbol SXL on the TSXV exchange and based in New Brunswick, Canada, has signed a sale agreement on their Ferguson Brook mineral claim. The Ferguson Brook claim is one among almost 100 mineral claims in  SLAM Exploration’s  dossier. The sale announcement was made on 10th March 2021 and highlighted all details that all investors wish to know. Puma Exploration, another well-known junior resource Canadian company, has acquired a claim over the property. FERGUSON BROOK CLAIM DETAILS The Ferguson Brook claim consists of 42 claim units. The property covers 912 hectares of prospective land that has been sold to Puma Exploration. The property is adjacent to Puma Exploration’s William Brook gold project, allowing them the opportunity to expand their gold program. AGREEMENT DETAILS The agreement defines the Ferguson Brook Claim as two different properties. The first property referred to as “Property A” in the agreement comp...
Post a Comment
Read more

Platina Resources Limited signed a Joint Venture agreement with Chalice Mining for the Mt Narryer Gold Project

  PLATINA RESOURCES LIMITED  (ASX: PGM) (Platina or the Company) is a mineral resource exploration company based in Western Australia. The Company has inked a  JOINT VENTURE AGREEMENT WITH CHALICE MINING LIMITED , a mineral exploration and development company, to operate the Mt Narryer Gold Project. Terms of the Joint Venture Stage 1 earn-in : Initially, Chalice Mining will earn a  51% INTEREST  in the project by investing  AUD 600,000  within two years, which must include at least  AUD 150,000  in the first year Stage 2 earn-in : Chalice Mining can acquire an additional  24% INTEREST  in the project by investing an extra  AUD 1.8 MILLION  within the next two years Platina free cost carry : Once Chalice Mining has obtained a  75% INTEREST  in the Project, Platina Resources Limited will continue to be free cost carried until the Pre-Feasibility Study is completed Contribute & Dilute : After the Pre-Feasibility...
Post a Comment
Read more